cafepharmaNov 20, 2023
Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B sales forecast -- AZ launches digital clinical trials business --MSLs rejoice, overtaking sales reps as pharma’s prime information conveyors-- See more on our front page news http://bit.ly/w28kSd #bayer #bloodthinners #clinicaltrials #astrazeneca #msl #pharmarep #pharmamarketing #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma